Clinical Trial Finder Search Results

About the Fight CRC Clinical Trial Finder

This Trial Finder is a one-stop place to find and learn more about high-impact clinical trials for colorectal cancer patients with advanced colon or rectal cancer. Originally created by the late Dr. Tom Marsilje as a curated spreadsheet of trials, the FightCRC’s Trial Finder is a resource to find research studies that are open in your geography, and for which you may be eligible. The current data is now for metastatic, stage IV patients with both MSS and MSI-H status. The list of trials here is sourced from the ClinicalTrials.gov website and curated with Comments and Helpful Links. The searches can be focused on immunotherapy-centered trials and narrowed to studies enrolling patients who already have received immunotherapies.

Medical Disclaimer

The information contained in this website is not intended to recommend the self management of health problems, medical conditions or wellness. It is not intended to endorse or recommend any particular type of medical treatment, physician or treatment facility. Should any reader have any health care related questions, promptly call or consult your physician or healthcare provider. The information contained in this website should NOT be used by any reader to disregard medical and/or health related advice or provide a basis to delay consultation with a physician or a qualified healthcare provider. Fight Colorectal Cancer disclaims any liability based on information provided in this website.

Ubicación

MS status

Recruitment Status

Fase

Drogas

Inmunoterapia previa permitida

NCT ID

Title key word search

Fecha en que se añadió el juicio

From To

View:

Compact Expanded

PDF Excel CSV

NCT ID	Title	Fase	Date Added	Ubicación	Prior IO Allowed	CRC-directed	Status	Drogas	Etiquetas
NCT ID NCT03190941	TitleAdministración de linfocitos de sangre periférica transducidos con un receptor murino de células T que reconoce la variante G12V del RAS mutado en pacientes HLA-A*11:01	Fase Phase 1, Phase 2	Date Added 2017-06-19	Ubicación Maryland, United States	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Anti-KRAS G12V mTCR PBL, Cyclophosphamide, Fludarabine, High-dose Aldesleukin	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03170960	TitleStudy of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors	Fase Fase 1	Date Added 2017-05-31	Ubicación Arizona, United States California, United States Colorado, United States Connecticut, United States District of Columbia, United States Florida, United States Georgia, United States Illinois, United States Kansas, United States Kentucky, United States Louisiana, United States Massachusetts, United States Michigan, United States Minnesota, United States Missouri, United States Nebraska, United States Nevada, United States New Jersey, United States New York, United States Ohio, United States Oklahoma, United States Oregon, United States Pennsylvania, United States South Carolina, United States Texas, United States Utah, United States Virginia, United States Australia Bélgica Francia Alemania Italia Países Bajos España Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Activo, no recluta	Drogas Atezolizumab, Cabozantinib	Etiquetas MSS/ MMRp
NCT ID NCT03155061	TitleStudy of ONO-4578 With and Without ONO-4538 in Subjects Advanced or Metastatic Solid Tumors	Fase Fase 1	Date Added 2017-05-16	Ubicación Japón	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas ONO-4538, ONO-4578, Opdivo	Etiquetas MSS/ MMRp
NCT ID NCT03104439	TitleNivolumab e Ipilimumab y radioterapia en cáncer colorrectal y de páncreas con MSS y MSI alto	Fase Fase 2	Date Added 2017-04-07	Ubicación Massachusetts, United States	Prior IO Allowed No	CRC-directed Sí	Status Reclutamiento	Drogas Ipilimumab, Nivolumab, Opdivo, Yervoy	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03096093	TitleInvestigation of a Therapeutic Vaccine (ACIT-1) in Cancer	Fase Phase 1, Phase 2	Date Added 2017-03-30	Ubicación Reino Unido	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas ACIT-1	Etiquetas MSS/ MMRp
NCT ID NCT03093116	TitleA Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements	Fase Phase 1, Phase 2	Date Added 2017-03-28	Ubicación California, United States Colorado, United States District of Columbia, United States Florida, United States Georgia, United States Illinois, United States Louisiana, United States Maryland, United States Massachusetts, United States Michigan, United States Minnesota, United States Missouri, United States New Jersey, United States New York, United States North Carolina, United States Ohio, United States Pennsylvania, United States Tennessee, United States Texas, United States Virginia, United States Washington, United States Wisconsin, United States Australia Bélgica Canadá China Dinamarca Francia Alemania Hong Kong Hungary Italia Japón Corea, República de Países Bajos Polonia Singapur España Taiwán Reino Unido	Prior IO Allowed Sí	CRC-directed Sí	Status Reclutamiento	Drogas Oral repotrectinib (TPX-0005)	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03088150	TitleEnsayo COLLISION - Metástasis hepáticas colorrectales: Cirugía frente a ablación térmica	Fase Fase 3	Date Added 2017-03-23	Ubicación Países Bajos	Prior IO Allowed Sí	CRC-directed Sí	Status Unknown status	Drogas	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03069469	TitleEstudio de DCC-3014 en pacientes con tumores avanzados y tumor tenosinovial de células gigantes	Fase Phase 1, Phase 2	Date Added 2017-03-03	Ubicación California, United States Colorado, United States Florida, United States Massachusetts, United States New York, United States Oregon, United States Tennessee, United States Australia Canadá Francia Italia Países Bajos Polonia España Reino Unido	Prior IO Allowed Sí	CRC-directed No	Status Activo, no recluta	Drogas DCC-3014	Etiquetas MSS/ MMRp
NCT ID NCT03030378	TitlePembrolizumab e interleucina-12 recombinante en el tratamiento de pacientes con tumores sólidos	Fase Fase 1	Date Added 2017-01-25	Ubicación California, United States Colorado, United States Connecticut, United States Florida, United States Georgia, United States Iowa, United States Maryland, United States Massachusetts, United States Missouri, United States New Jersey, United States North Carolina, United States Ohio, United States Pennsylvania, United States Texas, United States Virginia, United States	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas Edodekin alfa, Pembrolizumab	Etiquetas MSI-H/ MMRd, MSS/ MMRp
NCT ID NCT03013218	TitleA Study of Evorpacept (ALX148) in Patients With Advanced Solid Tumors and Lymphoma (ASPEN-01)	Fase Fase 1	Date Added 2017-01-06	Ubicación Colorado, United States Connecticut, United States Massachusetts, United States Michigan, United States Washington, United States Corea, República de	Prior IO Allowed No	CRC-directed No	Status Activo, no recluta	Drogas 5-FU + Cisplatin, Evorpacept (ALX148), Pembrolizumab, Ramucirumab + Paclitaxel, Rituximab, Trastuzumab	Etiquetas MSS/ MMRp

Showing 261 to 270 of 299 entries